daunorubicin has been researched along with Cardiomegaly in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdelhamid, G; Alammari, AH; Althurwi, HN; Dawood, D; El-Kadi, AOS; El-Sherbeni, AA; Elshenawy, OH; Maayah, ZH; McGinn, E | 1 |
Li, BH; Lin, AH; Liu, Y; Sun, XM; Wang, DB | 1 |
Altman, DH; Rajurkar, MG; Raskin, MM | 1 |
Buja, LM; Ferrans, VJ; Henderson, ES; Mayer, RJ; Roberts, WC | 1 |
4 other study(ies) available for daunorubicin and Cardiomegaly
Article | Year |
---|---|
The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomegaly; Cardiotoxicity; Cells, Cultured; Cytochrome P-450 Enzyme System; Daunorubicin; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Fibrosis; Humans; Hydroxyeicosatetraenoic Acids; Male; Myocytes, Cardiac; NF-kappa B p50 Subunit; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Effect of selenium on the interaction between daunorubicin and cardiac myosin.
Topics: Animals; Antibiotics, Antineoplastic; Binding, Competitive; Cardiac Myosins; Cardiomegaly; Daunorubicin; Dose-Response Relationship, Drug; Male; Mice; Molecular Structure; Protein Binding; Sodium Selenite; Spectrometry, Fluorescence; Survival Rate | 2012 |
Daunomycin cardiac toxicity.
Topics: Cardiomegaly; Child; Child, Preschool; Daunorubicin; Drug Synergism; Heart; Heart Failure; Humans; Leukemia; Male; Radiography | 1973 |
Cardiac ultrastructural changes induced by daunorubicin therapy.
Topics: Adolescent; Adult; Cardiomegaly; Child; Child, Preschool; Chromatin; Daunorubicin; Female; Heart; Heart Failure; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Microscopy, Electron; Myocardium | 1973 |